[ad_1]
Artivion, a medical device company that makes implantable tissue for cardiovascular transplant applications, said its services were “disrupted” due to a cybersecurity incident.
in 8-K filing Georgia-based Artivion, formerly known as CryoLife, said with the Securities and Exchange Commission on Monday that it became aware of a cybersecurity incident involving “data acquisition and encryption” on Nov. 21. This suggests that the company has been subjected to a ransomware attack, but Artivion has not yet confirmed the nature of the incident and did not immediately respond to TechCrunch’s questions. No major ransomware group has claimed responsibility for the attack yet.
Artivion said it has shut down certain systems in response to the cyberattack, which the company says caused “disruption of some system and charging operations.”
Artivion, which reported third-quarter revenue of $95.8 million, said it did not expect the incident to have a material impact on the company’s financials.
[ad_2]